APR 11, 2016 9:00 AM PDT

WEBINAR: The epigenome in normal human placental development and its dysregulation in preeclampsia

Sponsored by: Zymo Research, Zymo Research
Speakers

Abstract
9:00 AM PT, 11:00 AM CT, 12:00 PM ET

Epigenetics defines the set of distinct and heritable molecular mechanisms able to influence gene expression without altering the primary genetic sequence. Common epigenetic factors include DNA modifications (methylation or hydroxymethylation), chromatin modifications (histone methylation or acetylation), and non-coding RNA expression (micro RNA or long non-coding RNA transcripts). The past decade has seen a marked increase in the number of scientific publications focusing on epigenetics research. As a result, the basic understanding as to how epigenetic pathways interact with diverse and consistently changing cellular environments to help regulate gene expression has grown as well. When normal epigenetic pathway function is disrupted, disease may result.

This webinar highlights two specific areas of biomedical research in which the dysregulation of epigenetic mechanisms play prominent roles in disease etiology. The first presenter, Dr. Peter Jones, will discuss the complex role that epigenetics dysfunction plays in cancer progression and how recent findings suggest novel avenues to exploit for therapeutic development. The second presenter, Dr. Than, explains how the developing placenta can be influenced by the surrounding maternal environment and identifies altered DNA methylation patterns at specific gene loci associated with prenatal health indications. The potential role for disease diagnostics will also be discussed.

Learning objectives:
  • Attendees will learn how epigenetics plays an important role in cancer and how those mechanisms might be exploited for therapeutic benefit.
  • Attendees will learn how epigenetics can influence prenatal health during pregnancy.
 

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
AUG 17, 2022 10:00 AM PDT
AUG 17, 2022 10:00 AM PDT
DATE: August 17, 2022 TIME: 10:00am PDT, 1:00pm EDT Detection and/or amplification of target DNA sequences by polymerase chain reaction (PCR) is a prevalent method in molecular biology. PCR...
SEP 29, 2022 11:00 AM PDT
SEP 29, 2022 11:00 AM PDT
Date: September 29, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Pharmacogenomic (PGx) testing is a dynamic and fascinating application for genetic testing. We'll review the bas...
Loading Comments...
Show Resources